Table 4. Factors associated with NSAID use-related complications among the population with GIT complications, Aseer region, Saudi Arabia .
p-value: Pearson's χ2 test; $Exact probability test; *p < 0.05 (significant)
NSAID: non-steroidal anti-inflammatory drugs; GIT: gastrointestinal tract
| Factors | Had GIT complications due to NSAIDs? | p-value | |||
| Yes | No | ||||
| No | % | No | % | ||
| Age in years | .326 | ||||
| 20-30 | 9 | 42.9% | 12 | 57.1% | |
| 30-40 | 17 | 48.6% | 18 | 51.4% | |
| 40-50 | 10 | 43.5% | 13 | 56.5% | |
| > 50 | 6 | 25.0% | 18 | 75.0% | |
| Gender | .427 | ||||
| Male | 30 | 43.5% | 39 | 56.5% | |
| Female | 12 | 35.3% | 22 | 64.7% | |
| Smoking | .049$ | ||||
| Current smoker | 14 | 51.9% | 13 | 48.1% | |
| Ex-smoker | 3 | 75.0% | 1 | 25.0% | |
| Non-smoker | 25 | 34.7% | 47 | 65.3% | |
| Time to have NSAIDs | .633 | ||||
| After meals | 25 | 41.0% | 36 | 59.0% | |
| Before meals | 12 | 46.2% | 14 | 53.8% | |
| Any time | 5 | 31.3% | 11 | 68.8% | |
| Frequency of taking NSAIDs / day | .525$ | ||||
| One time | 16 | 34.8% | 30 | 65.2% | |
| Two times | 16 | 47.1% | 18 | 52.9% | |
| Three times | 8 | 50.0% | 8 | 50.0% | |
| 4 / more times | 2 | 28.6% | 5 | 71.4% | |
| Formula using NSAIDs | .046* | ||||
| Tablet / capsule | 38 | 45.2% | 46 | 54.8% | |
| Injection | 4 | 21.1% | 15 | 78.9% | |
| Had chronic health problems | .876 | ||||
| Yes | 20 | 40.0% | 30 | 60.0% | |
| No | 22 | 41.5% | 31 | 58.5% | |
| Use other drugs? | .298 | ||||
| Yes | 18 | 47.4% | 20 | 52.6% | |
| No | 24 | 36.9% | 41 | 63.1% | |